Intracerebroventricular administration of β-endorphin increases the expression of c-fos and of corticotropin-releasing factor messenger ribonucleic acid in the paraventricular nucleus of the rat
- 29 January 1996
- journal article
- Published by Elsevier in Brain Research
- Vol. 707 (2) , 189-195
- https://doi.org/10.1016/0006-8993(95)01234-6
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Chlordiazepoxide attenuates stress-induced activation of neurons, corticotropin-releasing factor (CRF) gene transcription and CRF biosynthesis in the paraventricular nucleus (PVN)Molecular Brain Research, 1995
- Intracerebroventricular administration of corticotropin-releasing factor inducesc-fos mRNA expression in brain regions related to stress responses: comparison with pattern ofc-fos mRNA induction after stressBrain Research, 1993
- Enhancing Effect of Intracerebrally Infused β-Endorphin Antiserum on the Secretion of Cortisol in Foot-Shocked SheepNeuroendocrinology, 1993
- Early induction of c-fos precedes increased expression of corticotropin-releasing factor messenger ribonucleic acid in the paraventricular nucleus after immobilization stress.Endocrinology, 1992
- Widespread expression of corticotropin-releasing factor messenger RNA and immunoreactivity in the rat olfactory bulbBrain Research, 1989
- Dual effects of (D-Ala2,Met5)-enkephalinamide on CRF and ACTH secretionPeptides, 1987
- The Effect of Glucose and Free Fatty Acids on Growth Hormone (GH)-Releasing Factor-Mediated GH Secretion in Rats*Endocrinology, 1986
- The satiety effect of growth hormone-releasing factor in ratsBrain Research, 1985
- Differences in Hypothalamo-Pituitary-Adrenocortical Activity in the Rat after Acute and Prolonged Treatment with MorphineNeuroendocrinology, 1984
- D-Ala2-Met-Enkephalinamide, a Potent Opioid Peptide, Alters Pituitary-Adrenocortical Secretion in Rats*Endocrinology, 1982